Parental Bereavement (Leave and Pay) Bill

Mike Wood Excerpts

2nd reading: House of Commons
Friday 20th October 2017 Commons Chamber

[Mike Wood (Dudley South) (Con)]

I thank my hon. Friend for taking forward the excellent work begun by my hon. Friend the Member for Colchester (Will Quince) in the previous Session. He rightly says that most employers would grant leave under such terrible circumstances, were it asked for. Is not the point of the Bill that no parent should, in almost unimaginably horrible and difficult circumstances, have to make such a request and fear what the answer might be?

[Kevin Hollinrake]

My hon. Friend is absolutely right. Of course, most employers do the right thing, working with the people affected so that they get whatever support and time off they need, and maintaining their levels of pay through that period of time.

During our consultations on the Bill, our excellent parliamentary digital engagement team facilitated a Facebook debate, in which I took part. Some charities and the campaign organisation, 38 Degrees, also provided us with a number of examples of employers and line managers who offered inappropriate levels of support. For instance, a parent told us that their employer— an NHS body—offered them only five days’ leave following the sudden passing of their youngest daughter, with any additional time having to be taken as annual leave. Brendan from Newcastle told us that he did not get any paid leave and was sacked nine months later. Gillian from Milton Keynes did not receive the appropriate support when she lost her daughter 13 years ago. She told us that the measures proposed in the Bill would have meant that she and her partner could have grieved together, and provided help and support for their other children.

No employee should even have to think about being at work when they desperately need some time away to grieve for a lost child. Yet according to a Rainbow Trust survey, around 9% of parents said that their employer was not at all supportive. I ask those employers to consider their position. What is the point of having a parent in the workplace who has had no time off to grieve? What effect do those employers think it has on the bereaved parents’ attitude to their workplace and, indeed, on other people in the workplace? I strongly recommend that all employers and managers read the excellent ACAS guidelines on bereavement, which clearly detail best practice for financial and emotional support.

I will now set out the detail of the Bill. The Bill will provide two weeks’ leave for all employees who lose a child below the age of 18. This will be a day-one right. Those key points are established on the face of the Bill, which deliberately leaves some other details to regulations. This leave will be protected and a person should suffer no form of detriment in the event that they find themselves having to take the leave. Crucially, the Bill will give parents an important choice, allowing them to make a decision on what is best for their needs, when they might otherwise be reliant on the good will of their employer.

Nuclear Safeguards Bill

Mike Wood Excerpts

2nd reading: House of Commons
Monday 16th October 2017 Commons Chamber

[Rebecca Long Bailey]

I will just make some progress, if I may.

We have to be clear that the measures set out in the Bill are just a part of the process of disentangling ourselves from Euratom and replacing its provisions with satisfactory alternatives that allow the UK’s nuclear industry to continue working smoothly in conjunction with its international partners and not to face a cliff edge of uncertainty. Indeed, the position paper on the nuclear industry issued by the UK Government in the spring of this year lists a number of key activities of Euratom that are not covered by the nuclear safeguarding issue, but which are essential to place into a UK legislative framework if a tenable regime for nuclear power in the UK is to be created before Brexit.

One example is that we will need to reach an agreement on the international supply chain for nuclear reactors. Without such an arrangement in place, it is possible that the existing nuclear power stations such a Sizewell B will be forced to close until such time as the agreement is sorted out. The UK will need to conclude individual and separate nuclear co-operation agreements with non-EU countries such as Australia, Canada, Japan, South Africa, Kazakhstan, the United States of America and others. We will need to agree new inspections with the IAEA. The status of supply chains such as nuclear isotopes for medical treatment will need to be maintained, supplied by reactors in EU countries. There is the issue of research in nuclear technology including, importantly, the fusion research carried out at the Joint European Torus facility in Culham, which the Secretary of State has already mentioned. These are all at serious risk if a fully worked-out series of agreements is not in place to allow these activities continuous operation. Working out a way to honour our safeguarding commitments under the nuclear non-proliferation treaty is only the start of the process and we should not delude ourselves that achievement of that solves the Euratom issue. It does not.

[Mike Wood (Dudley South) (Con)]

The hon. Lady’s position seems to be that there is legal uncertainty about whether it is necessary for the UK to leave Euratom and that we should have left the issue until further in the negotiations, finding out whether we were leaving later on in the process. Would that not have just left rather less time to prepare if we did have to leave?

[Rebecca Long Bailey]

The point I am making is that there is legal uncertainty. Sadly, the Prime Minister firmly closed the door on the Euratom position, when it could have been left open. We could have passed this Bill through Parliament while questioning whether the legal position on Euratom membership was as the Commission states.

--- Later in debate ---

[Drew Hendry]

No, I am going to make a bit of progress.

In its paper on radioisotopes and Brexit, the Royal College of Radiologists outlines the crucial role that radioisotopes play in medical advances. The majority of the UK’s supply of radioisotopes, used in scanning and the systemic and internal treatment of a wide range of cancers, is imported from Europe and further afield. The most commonly used radioisotope is used in 700,000 medical procedures each year, and global demand is growing by 0.5% a year. Radioisotopes are used for the diagnosis and treatment of various diseases, including cancers, cardiovascular conditions and brain disorders. The UK does not have any reactors capable of producing those isotopes, and because they decay rapidly—often within a matter of hours or days—hospitals in the UK cannot stockpile them and must rely on a continuous supply from reactors in the EU.

[Mike Wood]

Does the hon. Gentleman accept that the isotopes he refers to are not special fissile nuclear material, and so they are not regulated by international safeguards such as these and would not be affected if we left Euratom?

[Drew Hendry]

It is telling that Conservative Members are willing to ignore all advice from experts in the nuclear industry in order to uphold their position that we must have the hardest possible Brexit.

European Union (Approvals) Bill

Mike Wood Excerpts

2nd reading: House of Commons
Tuesday 4th July 2017 Commons Chamber

[Margot James]

I heartily agree with my hon. Friend that we will continue to foster good relations with our EU friends long after we leave the European Union. Keeping that in mind, we are content that all four decisions that the Bill addresses are reasonable, proportionate and in keeping with our best interests, and will not result in any additional financial burdens on the UK.

As I have said, article 352 decisions must be agreed by all EU member states unanimously. When all member states are in a position to vote on the decision, the European Council will schedule a meeting of the Council of the European Union. If all member states vote to approve the draft decisions at that meeting, the European Parliament will be asked in turn to approve the draft decisions. If it does so, the decisions are adopted into EU law. All member states apart from the UK have agreed the EU-Canada decisions, and all member states except the UK and Germany have agreed the Fundamental Rights Agency decisions. We do not believe that any of the draft decisions should be considered contentious in any way.

[Mike Wood (Dudley South) (Con)]

It has been suggested that, as we negotiate our exit from the European Union, the United Kingdom should abstain in decisions in the Council. Will the Minister explain what the impact of a British abstention would be on those decisions?

[Margot James]

I assure my hon. Friend that, were we not to pass the Bill this afternoon, the draft decisions would not proceed. We are still full members of the European Union and therefore our consent is required for the draft decisions to take effect.

Energy Price Cap

Mike Wood Excerpts

Monday 3rd July 2017 Commons Chamber

[Greg Clark]

This is a wake-up call for the industry. A model in which consumers who are known not to switch can be milked to pay a subsidy for other consumers in an unfair way—the CMA identified “unilateral market power”, which enables firms to exploit their position—has to come to an end.

[Mike Wood (Dudley South) (Con)]

While I welcome proposals to make it easier to switch away from poor deals, does my right hon. Friend agree that Ofgem needs to go much further than it suggested in its letter to him this morning to protect consumers from exploitation?

[Greg Clark]

There is a clear expectation that I want the detriment that the CMA has identified to be tackled once and for all. Ofgem has said that it will consult consumer groups, and I hope and expect that those consumer groups will share my hon. Friend’s analysis.